NCT07088146 Dexamethasone in Prolonging the Duration of Spinal Anesthesia Among Pregnant Patients
| NCT ID | NCT07088146 |
| Status | Recruiting |
| Phase | Phase 4 |
| Sponsor | Rawalpindi Medical College |
| Condition | Spinal Anesthesia |
| Study Type | INTERVENTIONAL |
| Enrollment | 110 participants |
| Start Date | 2025-07-20 |
| Primary Completion | 2025-10-20 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
Phase 4 studies follow an already-approved treatment in real-world conditions to monitor long-term safety and effectiveness.
This trial targets 110 participants in total. It began in 2025-07-20 with a primary completion date of 2025-10-20.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Lower segment C section is one of the most commonly performed surgeries worldwide. It is performed in spinal anesthesia. During Spinal Anesthesia a local anesthetic drug is administered in a space surrounding spinal cord and it blocks nerves originating from spinal cord providing both anesthesia and analgesia. This technique avoids harmful exposure of drugs to the baby inside the womb of mother. However this technique provides anesthesia and analgesia of limited duration which can be prolonged by addition of drugs to patient management regimen. One such drug is Dexamethasone which is a steroid commonly administered in the peri-operative period.
Eligibility Criteria
Inclusion Criteria: * American Society of Anesthesiologists (ASA) class: II and above. * Elective Cesarean section under Spinal Anesthesia. Exclusion Criteria: * Gestational diabetes * Body mass index \>35 kg/m2 * Diabetes mellitus * Adrenal insufficiency * Chronically receiving steroids * Allergic to study medications * Sensory block level less than T4
Contact & Investigator
Abeera Zareen, MBBS,FCPS
STUDY CHAIR
Rawalpindi Medical College
Frequently Asked Questions
Who can join the NCT07088146 clinical trial?
This trial is open to female participants only, aged 16 Years or older, up to 40 Years, studying Spinal Anesthesia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
What phase is the NCT07088146 trial and what does that mean for participants?
Phase 4 studies are conducted after a treatment has been approved. They monitor long-term safety and real-world effectiveness in a broader patient population.
Is NCT07088146 currently recruiting?
Yes, NCT07088146 is actively recruiting participants. Contact the research team at Huda8829@gmail.com for enrollment information.
Where is the NCT07088146 trial being conducted?
This trial is being conducted at Rawalpindi, Pakistan.
Who is sponsoring the NCT07088146 clinical trial?
NCT07088146 is sponsored by Rawalpindi Medical College. The principal investigator is Abeera Zareen, MBBS,FCPS at Rawalpindi Medical College. The trial plans to enroll 110 participants.